Rossby Financial’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$21.7K Sell
96
-2
-2% -$424 ﹤0.01% 1221
2026
Q2
$21.2K Buy
98
+45
+85% +$8.61K ﹤0.01% 946
2026
Q1
$9.7K Buy
53
+39
+279% +$7.19K ﹤0.01% 1263
2025
Q4
$2.46K Buy
+14
New +$2.29K ﹤0.01% 1308

Other funds holding BIIB

Rossby Financial's BIIB Position: Q3 2026 in Review

Rossby Financial reduced its Biogen (BIIB) stake by 2% in Q3 2026, selling an estimated $424 and leaving 96 shares worth $21.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1221.

Rossby Financial first reported a position in BIIB in Q4 2025 and has held it in 4 quarters since. 1,056 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Rossby Financial held 96 shares of Biogen worth $21.7K as of Q3 2026.
  • Rossby Financial sold 2 Biogen shares in Q3 2026, an estimated $424.
  • Biogen made up ﹤0.01% of Rossby Financial's portfolio in Q3 2026, its #1221 holding.
  • Rossby Financial first reported a position in Biogen in Q4 2025 and has held it in 4 quarters since.
  • 1,056 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Rossby Financial's 13F filing for Q3 2026, filed 5 Nov 2026.